| | | | | |
EDIT Editas Medicine, Inc. Common Stock | €2,5602 | +5,16% | €385,87M | €959,05K | |
NPFD Nuveen Variable Rate Preferred & Income Fund | €16,0934 | +0,35% | €385,84M | €27,03K | |
AMCX AMC Global Media Inc. Class A Common Stock | €10,1793 | -0,85% | €385,53M | €117,17K | |
| €14,3173 | +0,46% | €384,94M | €56,41K | |
GBFH GBank Financial Holdings Inc. Common Stock | €18,4240 | +1,94% | €384,88M | €30,96K | |
KBON Karbon Capital Partners Corp. Class A Ordinary Shares | €8,7680 | +0,20% | €384,77M | €6,064 | |
CABA Cabaletta Bio, Inc. Common Stock | €2,4129 | -0,54% | €384,25M | €2,15M | |
| €15,1014 | +0,00% | €384,14M | €541,49K | |
| €16,2545 | +59,26% | €383,44M | €10,85M | |
CZNC Citizens & Northern Corporation | €22,1088 | +0,78% | €382,40M | €11,74K | |
GLAD Gladstone Capital Corp | €17,0161 | +0,82% | €381,90M | €48,39K | |
SRTA Strata Critical Medical, Inc. Class A Common Stock | €5,2634 | +2,27% | €381,58M | €486,27K | |
PRTA Prothena Corporation plc Ordinary Shares | €7,9362 | +0,44% | €381,46M | €192,70K | |
| €12,5091 | +2,91% | €381,01M | €173,57K | |
| €4,1544 | -3,71% | €380,97M | €572,61K | |
